Boston Scientific (Boston Scientific) 3-Year FCF Growth Rate

: 18.70% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

Boston Scientific's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.00.

During the past 12 months, Boston Scientific's average Free Cash Flow per Share Growth Rate was 83.30% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Boston Scientific was 170.30% per year. The lowest was -56.80% per year. And the median was -2.80% per year.

Competitive Comparison

For the Medical Devices subindustry, Boston Scientific's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boston Scientific 3-Year FCF Growth Rate Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Boston Scientific's 3-Year FCF Growth Rate falls into.

Boston Scientific 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Boston Scientific (NYSE:BSXpA.PFD) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Boston Scientific 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Boston Scientific's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Boston Scientific (Boston Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (NYSE:BSXpA.PFD) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

BSX:USA BSX:Mexico 1BSX:Italy BSX:Germany BSX:Germany BSX:Germany B1SX34:Brazil BSXC:Austria

Address

300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234

Website

https://www.bostonscientific.com

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.